Hope Remains For Alzheimer's Sufferers
The National Institute of Clinical Excellence (NICE) who last week rejected appeals to allow patients with mild Alzheimer's to receive the life-changing medication donepezil (Aricept®) will hopefully re-appraise their decision in 3 years time according to neurologist Professor Robert Kerwin in an article published in the November issue of the medical journal Future Neurology. [click link for full article]
posted by Smile Community @ 3:07 AM
0 Comments:
Post a Comment
<< Home